CARDIOPATCH (Network of Excellence for the development of Advanced Therapies of Myocardial Infarction treatment based on regenerative medicine and 3D printing), which aims to create a new treatment through regenerative medicine and 3D printing for patients who have suffered a myocardial infarction, has developed a digital platform to connect the key actors of the biotechnology sector and the 3D printing technologies from Southwestern Europe.

This project involves the participation of Prof. Lina Badimon and Dr. Gemma Vilahur from the Institut de Recerca Hospital de la Santa Creu i Sant Pau – IIB Sant Pau. “The achievement of this project will allow us to get functionalised patches with therapeutic proteins and enriched with stem cells. As a result, we will gain the capacity to regenerate damaged tissues in heart attack patients“, stated both researchers.

The characteristics and services of this interactive platform, which is integrated in its official website, will be presented today, 30th of April, at 4:00 P.M. CEST in a virtual encounter. The event is open to the public and the inscriptions can be made following this link.

During the webinar, not only the website of CARDIOPATCH project will be presented officially, but also the main services that are included. Specifically, the members of the consortium of the project will explain the functioning of the funding opportunities search tool and the space dedicated to encourage and impulse synergies and collaborative projects.

Besides, it will be presented the map of capacities as well. This interactive environment allows the user to travel geographically through Southwestern Europe searching for research institutions and entities focused on the biomedical sector and 3D printing technologies, as well as research projects working in these fields.

CARDIOPATCH platform will allow joining the network to all the entities interested in it in order to enjoy the project’s services and be able to develop new collaborations and innovation projects.

“With this virtual network, CARDIOPATCH will foster cooperation between the different actors that work in the R&D applied to the biomedical sector in Southwest Europe. The platform is provided by tools and services that will help to create synergies and impulse the networking. It will also be an informative space where the project’s advances in cardiac regenerative medicine will be shared”, explains Felipe Prósper, director of the Navarra University Clinic Cell Therapy Department and project chief scientific officer.

Co-funded by the EU Interreg Sudoe Programme, via the European Regional Development Fund (ERDF), CARDIOPATCH is led by Clínica Universidad de Navarra. The project’s consortium is also made up by CIMA University of Navarra, via the Foundation for Applied Medical Research, the Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, LEARTIKER technology centre, communication agency GUK, Centre Hospitalier Universitaire de Toulouse, the University of Montpellier (UM) – Institut des Biomolécules Max Mousseron (IBMM), GenIbet Biopharmaceuticals and the Instituto de Biologia Experimental e Tecnológica.

The project also has the support of associate partners Viscofan, Sodena and the Nouvelle-Aquitaine, Euskadi, Navarre Euroregion (NAEN), among others.

Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

The Bigas Lab finds Notch self-inhibitio...

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

It has been found that the population of haematopoietic stem cells (HS...

Photos Stream